Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-06

FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Mesalamine from Actavis Pharma, Inc. (generic Mesalamine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)